LavannyaMPanditMD

Critical Care Medicine, Pleural Disease

Assistant Professor, Pulmonology, Baylor College of Medicine

Dr. Pandit is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Baylor College of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2008
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2000 - 2003
University of Texas Southwestern Medical SchoolClass of 2000

PubMed

34 citations
Admission for COPD Exacerbation Is Associated with the Clinical Diagnosis of Pulmonary Hypertension: Results from a Retrospective Longitudinal Study of a Veteran Popul...
Sarah K. Medrek, Amir Sharafkhaneh, Andrew Spiegelman, Arnav Kak, Lavannya M. Pandit
COPD. 2017-07-17
17 citations
Idiopathic pulmonary fibrosis and pulmonary hypertension: Heracles meets the Hydra.
Keshava Rajagopal, Andrew Bryant, Sandeep Sahay, Nancy Wareing, Yang Zhou
British Journal of Pharmacology. 2021-01-01
38 citations
Clinical and Immunological Factors in Emphysema Progression. Five-Year Prospective Longitudinal Exacerbation Study of Chronic Obstructive Pulmonary Disease (LES-COPD)
Sivasubramanium V. Bhavani, Chu-Lin Tsai, Sarah Perusich, Sean Hesselbacher, Harvey O. Coxson
American Journal of Respiratory and Critical Care Medicine. 2015-11-15

Journal Articles

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Gerard J Criner, Lavannya Pandit, The New England Journal of Medicine

Common Enzyme Deficiency Linked with COVID SeverityMarch 29th, 2023
Why Science Shouldn’t Be ‘Colorblind’June 18th, 2021
Trial Results Show Potential Benefits of Tocilizumab for COVID-19February 25th, 2021
Join now to see all